Graves Disease Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The Graves Disease Market size is expected to grow at an annual average of 6% during 2022-2028. Graves disease is an immune system disorder that stimulates the thyroid gland to release excess thyroid hormones, leading to hyperthyroidism. Known as Badou’s disease in continental Europe and Graves’ disease in the United States, the disease affects more women than men. The male to female ratio of hyperthyroidism due to Graves’ disease is 7-8:1. It is usually a disease of young women, but can occur at any age. There are various treatments for the diagnosis of this disease, including antithyroid drugs, radioiodine ablation, and surgery. This treatment controls the overproduction of thyroid hormones.

The following segmentation are covered in this report:

By Application

• Mining
• Transport and Logistics Industry
• Agriculture
• Industrial and Manufacturing
• Food Production Industry
• Others

By Type

• Anti-Thyroid Drugs
• Lodine andLodides
• Radioactive Lodine
• Lonic Inhibitors

Company Profile

• Abbott Laboratories
• GlaxoSmithKline plc
• Merck and Co
• Pfizer, Inc
• RLC LABS
• AbbVie, Inc
• Mylan N.V
• Allergan, plc

Scope of the report

The research study analyses the Graves Disease Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Graves Disease Market Report

• What was the Graves Disease Market size in 2022 and 2028; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Graves Disease Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.